Question

Is stem cell therapy for Rheumatoid Arthritis worth it?

Outside a properly authorised study, evidence does not support a paid cell product as a substitute for established RA therapy. An independent rheumatologist should assess disease control, alternatives, trial design, risks and financial exposure.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards

Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease that can damage joints and other organs. MSC and other cell products are investigated for immune modulation, but they are distinct from disease-modifying antirheumatic drugs (DMARDs) and do not have established ability to reverse structural joint damage. Autologous origin, local injection or an anti-inflammatory laboratory signal does not prove clinical efficacy.

Am I a candidate? → · Rheumatoid Arthritis: full overview → · Rheumatoid Arthritis cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

More on this condition

Explore all sections · Data & downloads

Is stem cell therapy for Rheumatoid Arthritis worth it?

How stem cells are studied for Rheumatoid Arthritis

Sources & further reading

More questions about Rheumatoid Arthritis

More on this condition

Compare cell-therapy evidence, registered studies and published price observations.